These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26462053)

  • 1. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
    Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
    Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators.
    Sato M; Ohta K; Kaise A; Aoto S; Endo Y
    Bioorg Med Chem; 2016 Mar; 24(5):1089-94. PubMed ID: 26822566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
    Ohta K; Ogawa T; Kaise A; Endo Y
    Bioorg Med Chem; 2014 Jul; 22(13):3508-14. PubMed ID: 24837157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
    Ohta K; Ogawa T; Kaise A; Endo Y
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
    Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
    ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
    Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates.
    Ohta K; Ogawa T; Kaise A; Endo Y
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3213-6. PubMed ID: 26077489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides.
    Kucinska M; Giron MD; Piotrowska H; Lisiak N; Granig WH; Lopez-Jaramillo FJ; Salto R; Murias M; Erker T
    PLoS One; 2016; 11(1):e0145615. PubMed ID: 26730945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
    J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
    Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the influence of terminal groups at the C2-propyl side chain of 1,1-bis(4-hydroxyphenyl)-2-phenylpent-1-ene and 1,1,2-tris(4-hydroxyphenyl)pent-1-ene on the estrogen receptor binding and the estrogenic/anti-estrogenic properties.
    Gust R; Lubczyk V
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):57-70. PubMed ID: 12943745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and computational insights on the recognition mechanism between the estrogen receptor α with bisphenol compounds.
    Cao H; Wang F; Liang Y; Wang H; Zhang A; Song M
    Arch Toxicol; 2017 Dec; 91(12):3897-3912. PubMed ID: 28616630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the molecular basis of action of ring D aromatic steroidal antiestrogens.
    Alvarez LD; Veleiro AS; Burton G
    Proteins; 2015 Jul; 83(7):1297-306. PubMed ID: 25921217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
    Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
    Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
    Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
    Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Synthesis of Novel Breast Cancer Therapeutic Drug Candidates Based upon the Hydrophobic Feedback Approach of Antiestrogens.
    Ohta K; Kaise A; Taguchi F; Aoto S; Ogawa T; Endo Y
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31683895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.